11 December 2020 4 Min Read
Sanofi and GSK delay vaccine launch to late 2021
The companies said the vaccine, which is a different type to the Pfizer-BioNTech one, showed an insufficient immune response in older people
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In